| Biomarker ID | 896 |
| PMID | 22493721 |
| Year | 2012 |
| Biomarker | Ring finger protein 19A (RNF19A) |
| Biomarker Basis | Expression Based |
| Biomolecule | mRNA |
| Source | Blood |
| Subjects | Humans |
| Regulation | Upregulated in PCa (>2 fold) |
| Odds Ratio/Hazard Ratio/Relative Risk | NA |
| Effect on Pathways | NA |
| Experiment | Prostate Cancer vs healthy controls |
| Type of Biomarker | Diagnostic |
| Cohort | 10 patients with PCA and 10 healthy men were used as control in this study as a training set. For validation, 33 prostate cancer patients and 19 healthy patients were chosen. |
| Senstivity | NA |
| Specificity | NA |
| AUC | 0.727 |
| Accuracy | NA |
| Level Of Significance | p = 0.0066 |
| Method Used | qRT-PCR |
| Clinical | No |
| Remarks | NA |
| Clinical Trial Number | NA |
| Degree Of Validity | Validated on independent patient dataset |
| Technical Name | RNF19A |